Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2022-07-29 | 2022-10-21 | 165730 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-10-17 | 2022-11-20 | 171889 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-11-11 | 2022-12-09 | 174347 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 190005 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-11-24 | 2023-12-08 | 211502 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213550 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-02 | 2024-03-08 | 218385 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-16 | 2024-03-08 | 219837 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229416 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236237 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236255 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-09-05 | 2024-09-20 | 236864 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2024-10-17 | 2024-11-15 | 240586 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-11-07 | 2024-11-15 | 242208 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2022-04-29 | 2022-06-28 | 159713 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-09-01 | 2022-09-23 | 168424 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-02-09 | 2023-09-22 | 184092 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Avoided shortage | 2023-03-09 | 2023-09-15 | 186580 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-09-22 | 186583 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |